CLS: Order from ClearPoint Neuro - Redeye

Redeye endorses that CLS has received an order worth SEK5.5m from ClearPoint Neuro. CLS received FDA clearance for its MR-guided laser ablation system in neurosurgery a few weeks ago, and the order is a consequence of the initiated rollout in the US. We will provide an update in connection with the Q3 report, where we review the case and our forecasts.

Länk till analysen i sin helhet: https://www.redeye.se/research/858349/cls-order-from-clearpoint-neuro?utm_source=finwire&utm_medium=RSS